ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001355.1|U-68204_1 # 69 # 1904 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=15bp;gc_cont=0.689	BGC0001355.1|U-68204_1 	69	1904	-	Loose	450	28.8758	aadA22	50.0	3002619	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTGCGGTATTGCCGGCTGGGTTTCGTACCGTCGGGATCTGACGCAGCAGTCGCAGATCCTCGACGCGATGACCGAGACCATGGCCTGCCGCGGTCCCGACGCACGAGACACGTGGGCGGACCGGCACGCCGCCCTTGGCCACCGGCGGCTCGCCGTCATCGACCTGCCCGGCGGCGCGCAGCCGATGCGGGTGGACACCGGGGACGGCGAAGTGGTGATGGTCTATTCGGGAGAGACCTACAACTACGCCGAGCTGCGCGCCGAACTCCGCCGCCGCGGGCACCGTTTCACCACCGACTCGGACACCGAGGTGGTGCTCCGCGGATATGTGGAGTGGGGCGAGGCGATCGGTGAGCACCTGAACGGCATGTTCGCCTTCGCCGTCTGGGACGCGCGCACCGAGAAGCTCGTCATGGTCCGGGACAGGCTGGGCGTCAAGCCCTTCTACTACTACGAGACCGAGGACGGCGTCCTCTTCGGCTCCGAACCCAAGGCGATCCTCGCGAACCCCCTCTGCTCCGCCGTCGTCGGCCTGGACGGGCTGCGGGAGATGTTCTCCTTCGCCAAGACCCCGGGGCACGCGATCTGGGAGGGCATGCGCGAGCTGCGCCCCGGTCACGTCGCCGTGACCGACGTCGACGGGCTGCGGGAGTACGCCTACTGGCGCCTTGAGGCGGACGACCACACGGACGACCAGCAGGCCACCGTCGCGCACGTCAGGGAGCTGCTGGAGGACATCATCTCCCGGCAGCTCGTCGCGGACGTCCCGCGCTGCACGCTGCTCTCCGGCGGTCTCGATTCCTCCGTCATCACCGCACTCGCGGCCCGGCAGCTCAGGCAGCAGGGGGAGACGGTCCGCACCTTCGCCGTGGACTTCCCGGACCAGGAGGAGAACTTCAGGGCGATCGACCTCTCCCCCACCCGGGACACCCCGTACGCGCACGCGGTGGCCGAGCACGTGGGGAGCGACCACCGGGACATCGTGCTCCACGGCAGCGCGCTGGCCGACCCGGAGGTACGGCGGGCGGCCGTCGGCGCACGTGACTTCCCGAACGGGATCGGCGACCGCGACAACTCGCTTCACCTCCTCTTCAAAGCCGTCCGCGAACACTCGACGGTGGCGCTCTCCGGGGAGTCGGCGGACGAGTTGTTCGGGGGCTACCCGTGGTTCCACGAGGACAGGTTCCGCTACGCGGACACCTTCCCCTGGCTCGCGGGCAAGGGCTCCCTCTTCGAAGCGGGCGGCCTCCTGGACGACGACCTGTCACGCCGGCTCGACCTGGGAGCCTACGTCCGGGACCACTACCTCAGCGCCCTGAAGGAGGTCCCGCTCAAGGAGGGCGAGACCGGCCTGGAGAAGCAAATGCGCCAGGTCTGCTATCTGAACGTGACGCGGAAGATGCAGCCCCTGCTCGACCGCAAGGACCGGATGAGCATGGCGGCCGGGCTCGAGGTGCGTGTCCCGTTCTGCGACCACCGTCTCGTTCAGTACGTCTTCAACGCCCCGTGGTCGCTGAAGGCGTTCGACGGCAGGGAGAAGAGCCTTCTGCGCGCCGCGACACGCGATCTGCTGCCACCGTCCGTGGCCGACCGCAAGAAGAGCGGCTACCCCAGCAGCTTCGACCCGCAGTACCTCAAGGCGGTCCAGTCCCAGGTCGCCGACCTGCTCGACCGCGACCACCCGGCACTGGCGCTGTGCAGCCGGGGCCGCCTGCGCGAGGCGATGAAGGCGGACAAGGACACCATCAGCCTCCAGCAGCGGACGGTACTGGAACGCTCGCTCGACCTGGCGACGTGGCTCGATCTACGGAACCCGACGCTGAAACTCGGCTGA	MCGIAGWVSYRRDLTQQSQILDAMTETMACRGPDARDTWADRHAALGHRRLAVIDLPGGAQPMRVDTGDGEVVMVYSGETYNYAELRAELRRRGHRFTTDSDTEVVLRGYVEWGEAIGEHLNGMFAFAVWDARTEKLVMVRDRLGVKPFYYYETEDGVLFGSEPKAILANPLCSAVVGLDGLREMFSFAKTPGHAIWEGMRELRPGHVAVTDVDGLREYAYWRLEADDHTDDQQATVAHVRELLEDIISRQLVADVPRCTLLSGGLDSSVITALAARQLRQQGETVRTFAVDFPDQEENFRAIDLSPTRDTPYAHAVAEHVGSDHRDIVLHGSALADPEVRRAAVGARDFPNGIGDRDNSLHLLFKAVREHSTVALSGESADELFGGYPWFHEDRFRYADTFPWLAGKGSLFEAGGLLDDDLSRRLDLGAYVRDHYLSALKEVPLKEGETGLEKQMRQVCYLNVTRKMQPLLDRKDRMSMAAGLEVRVPFCDHRLVQYVFNAPWSLKAFDGREKSLLRAATRDLLPPSVADRKKSGYPSSFDPQYLKAVQSQVADLLDRDHPALALCSRGRLREAMKADKDTISLQQRTVLERSLDLATWLDLRNPTLKLG	MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVIGK	232.32	gnl|BL_ORD_ID|1276|hsp_num:0	1392			381	474	spectinomycin; streptomycin
BGC0001355.1|U-68204_2 # 1963 # 2103 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0001355.1|U-68204_2 	1963	2103	-	Loose	600	21.557	CfxA6	26.09	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	GTGCTCGTCGCCCCCGAGGTGTTCGACCAGGACGACGACGGGATCGTCGTCCTCCTGAACCCGTCACCCACCGAGGACCTGCGCGAAGCGGTCGAGGAGGCCGCGGCCGTCTGCCCGGCGGATGTGATCCACGTGGAGTGA	MLVAPEVFDQDDDGIVVLLNPSPTEDLREAVEEAAAVCPADVIHVE	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	13.90	gnl|BL_ORD_ID|240|hsp_num:0	268			141	210	
BGC0001355.1|U-68204_3 # 2191 # 3411 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=CGAA;rbs_spacer=13bp;gc_cont=0.690	BGC0001355.1|U-68204_3 	2191	3411	-	Loose	300	28.1054	AAC(3)-VIa	29.33	3002540	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGATGTTGTCCAAGCCCGTCCCTCCGCTGCCTGCCGAACCCCCGCAGGGCTGCCCGTTCTCTCCCCCTCCGCAGTACGCGGTACTGCGCGTGGAGGAACCGGTCAGCCGTGTCTCGCTCCCGGACGGAAGCTGGGCCTGGCTGATCACCCGTTACGAGGACGTCCGGGCCGTTCTCTCCGACCCGCGGTTCAGTTCGGACTCGACCGCCCCGGGTTTTCCGCGCAGCGGCATGGTCACTGCCGGGGAATCGGGCAGCCTGATCCGGACGGACCCTCCTGAGCACACCCGGCGTCGGCGGATGCTCACGCCCCATGTCACGGTCAAGAGCGTGTCGGCCCTCCGCCCCCGCATCCAGGAGATCACCGACGGGCTGTGCGATGCGATGGAGGCCGAACGGGAGGCAGCGGGATCCCCCGGATACGTGGACCTCGTCAGGTCACTGGCCCTGCCGCTTCCGTCGTCGGTCATCAGCCTGCTGCTCGGGGTACCGGACGAGGACCACGACGTCTTCCAGAGCATCACCGCCACCGTGATGTCCCGGGTGAACGCCGAGGAGGAACGCACCGCCGCCCGCGCGCGACTGCTCTCCTACCTCCGCGAGCTGGTCGCCGGCAAGGAACGCAACCCCGGCGACGACATCCTGAGCGGACTGATCCACGACCGGATGGGAGCGGGCGAACTCACCCACGACGAGGTGGTGGGCACCGCCGCTCTCCTGCTGGTGGCCGGGCACGAGACCACCGCCAACATGATCGGCCTCGGCGCACTGACCCTCCTGCGGTACCCGCACGCGGCCGAGGAGCTGCGCAAGGACCCGTCGCTCATGCCGGGAGCCGTCGAGGAACTGCTCCGTTTCCACAGCGTCACCCGGAGCGGACCCCGTCGGGCGGCGACCGCCGACGTCGAGGTGGGCGGTCAGGTCATCAAGGCGGGAGAGGGCATCATCTGCGCGCTCGCCTCGGCGAACCGTGACCCCGAGGTGTTCCCGGATCCGGACGGGTTCGATCCGCAACGTGCCAACTCCCAGCATCACGTCGCCTTCGGCTACGGCGTCCACCAGTGCCTCGGCCAGGCGTTGGCGCGAGCCGAACTCCAGATCTCCCTGAACACCCTCCTGCGCCGCTTCCCGGAACTGCGTCTCGCCGTCGAGTTCGAAGACGTTCCGTTCCGCAGCGACATGCTGGTCTACGGCTGCCACGCACTGCCCGTGACGTGGTAG	MMLSKPVPPLPAEPPQGCPFSPPPQYAVLRVEEPVSRVSLPDGSWAWLITRYEDVRAVLSDPRFSSDSTAPGFPRSGMVTAGESGSLIRTDPPEHTRRRRMLTPHVTVKSVSALRPRIQEITDGLCDAMEAEREAAGSPGYVDLVRSLALPLPSSVISLLLGVPDEDHDVFQSITATVMSRVNAEEERTAARARLLSYLRELVAGKERNPGDDILSGLIHDRMGAGELTHDEVVGTAALLLVAGHETTANMIGLGALTLLRYPHAAEELRKDPSLMPGAVEELLRFHSVTRSGPRRAATADVEVGGQVIKAGEGIICALASANRDPEVFPDPDGFDPQRANSQHHVAFGYGVHQCLGQALARAELQISLNTLLRRFPELRLAVEFEDVPFRSDMLVYGCHALPVTW	MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTLVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAINEFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGAGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDAVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD	135.79	gnl|BL_ORD_ID|1012|hsp_num:0	1105			0	204	sisomicin; 6'-N-ethylnetilmicin; gentamicin
BGC0001355.1|U-68204_4 # 3471 # 4484 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=12bp;gc_cont=0.721	BGC0001355.1|U-68204_4 	3471	4484	-	Loose	880	26.5646	tet(L)	34.38	3000179	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCCGCTTGTTCATCCGCCCCGCTAAGAACAGGAGTGTGGGGGACCGGTTCGTACCTGCCCGATCACCTGGTGGACAATCAGGTCATCGCCGCATCGACGGGGGTGAGTCCCGAATGGATCGAGCGCAAGACCGGGATTCTCGAGCGGCGCTACGCGGCCGCACACCAGGCGACGTCCGACCTGGCCGCGGAGGCGGGCCGACGGGCGCTGGAGGACGCCGGGCTCAAGGCCGAGGAGCTGGGCTGGGTCATCGTCGCCACGACCACTCCTGACCAGCCCCAGCCACCCACCGCCGCCATCGTCCAGCAGAGTCTGGGCGCGGCCCGTGCCGCCGGCTTCGACGTCAACGCCGTCTGCGCGGGTTTCGTCGTCGCGTTGGACATCGCGGCGCGCATGCTCGCCGGCGACGGGGCGAGCCGCGGGCCGGCCCTGGTGATCGGCAGCGAGGTGTACTCACGCGTCATCGACCCCACCGACCGGCGTACCGCGCCGCTGTTCGGGGACGGGGCGGGGGCCGTGGTCCTCGGCCCGGTCTCCGGGCAGCGGGGCGTCCTGGGCAGTCACTCCACCACGGACAGCCGGTTGCTGGACCTCATCGGCATTTCCGCCGGCGGCAGCCGGACTCCGCCGTCCGCGGAGACCCTCGCCCGGGGTGAGCACTTCTTCCGCATGCGCGGGCGGGAGGTACGCGCGTACGTGATGCGCGAACTGCCCCGCGCGGTCCATGCCCTGCTGCAAGATCTCTCCGTCCCACCCGACCAGGTGCGGCACTTCATCCCCCATCAGGCCAACGGCGCGATGCTCGGGGAGGTTCTGGAGAACCTGGGCCTCCCCCGTGCGCGGGCTCACCTGCCCGTGGGCCGCCACGGGAACACGGGCGCCGCCTCCGTCCCGCTCGCACTCGACCACGCGCACCGCTCCGGAGAGCTGTCCGACGGAGACCTGGTCCTGCTGGCCGGGTTCGGAGGCGGCATGACGATGAGTGCCGCCCTGCTCGCCTGGGGCCTTTGA	MPACSSAPLRTGVWGTGSYLPDHLVDNQVIAASTGVSPEWIERKTGILERRYAAAHQATSDLAAEAGRRALEDAGLKAEELGWVIVATTTPDQPQPPTAAIVQQSLGAARAAGFDVNAVCAGFVVALDIAARMLAGDGASRGPALVIGSEVYSRVIDPTDRRTAPLFGDGAGAVVLGPVSGQRGVLGSHSTTDSRLLDLIGISAGGSRTPPSAETLARGEHFFRMRGREVRAYVMRELPRAVHALLQDLSVPPDQVRHFIPHQANGAMLGEVLENLGLPRARAHLPVGRHGNTGAASVPLALDHAHRSGELSDGDLVLLAGFGGGMTMSAALLAWGL	MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFMLTFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAFPALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIRKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIFPGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLGGLLFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPMEVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF	73.58	gnl|BL_ORD_ID|2349|hsp_num:0	1897			225	411	tetracycline
BGC0001355.1|U-68204_5 # 4498 # 5256 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=3bp;gc_cont=0.636	BGC0001355.1|U-68204_5 	4498	5256	-	Loose	200	26.1794	vanT gene in vanN cluster	39.13	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGGTTGACAGCCCCGTCGGCGCCGCCTCCTGGGTGCGCCGCTTTCACCCTTCACCCGAAGCAGAATTCCAACTTCTCTGTTTTCCGCACTCGGGTGGATCCGCCAGCTTCTTCTTTCCCTTCTCCCGGGACCTGTCGCCGACCATGGACGTGTGGGCCGTGCAGTACCCGGGCCGGCAGGACCGTCGCGCGGAGCCGAACATCCCGCACATACACGAGCTTGCCGATCGCGTCGCCGAGAGCGTGGGCCGGCAGCTCGACCGTCCTTACGCCCTGTTCGGGCACAGCATGGGCGCTACGCTGGCCTACGAGGTCGCCCTGCGACTGCAGGAATCGGGACAGGAGCCCGAGATGCTCTTCGTGTCAGGGCGTCCGGCCCCGCACCGTAACGTCGACACGGGGCTGCACCGGCTCTCGGACAGCGAGATCGTCGATGACATACGGGCCCTGGACGGCACGGGTTCGGAAGTATTCGGCGACGAGGAAGTACTCCGAATCATTCTTCCGGCGATACGCAGCGACTATCACGCCGCAGAGACCTATCAGTATGTCGCCGGTCCCGTTCTGAACTGCCCTCTCCGCGCTTTCACCGGCCTGTCCGACCCCAGGGTGCAGGTGAGCGAACTTCATCACTGGAGCAGTCACACCAATCAGTCGTTCCGGCTTGACGTGTTCTCCGGCGGCCATTTCTATCTCCTGGAAAACCACGACGCCATCGTGAAGGAAATCCAGGGCGCCCTGCTCCCCGTATCACCCTGA	MVDSPVGAASWVRRFHPSPEAEFQLLCFPHSGGSASFFFPFSRDLSPTMDVWAVQYPGRQDRRAEPNIPHIHELADRVAESVGRQLDRPYALFGHSMGATLAYEVALRLQESGQEPEMLFVSGRPAPHRNVDTGLHRLSDSEIVDDIRALDGTGSEVFGDEEVLRIILPAIRSDYHAAETYQYVAGPVLNCPLRAFTGLSDPRVQVSELHHWSSHTNQSFRLDVFSGGHFYLLENHDAIVKEIQGALLPVSP	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	36.00	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1371	1440	vancomycin
BGC0001355.1|U-68204_6 # 5283 # 5417 # 1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=GAA;rbs_spacer=8bp;gc_cont=0.622	BGC0001355.1|U-68204_6 	5283	5417	+	Loose	1700	20.7866	AxyY	33.33	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGACAAGCATTCGGCCGGGATCGGGCGGCGGCCTGCGTCCCACATGATGCATGAGAAAGTGAGGGGCCAACAATCCCCTACCGCTTTTGACCAGGCGCGTAGGGCCCCCTCAAACACCCTGGCCGCCTTTTAG	MDKHSAGIGRRPASHMMHEKVRGQQSPTAFDQARRAPSNTLAAF	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	4.21	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2541	2613	erythromycin; cefepime
BGC0001355.1|U-68204_7 # 5414 # 6865 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0001355.1|U-68204_7 	5414	6865	-	Loose	375	26.5646	tmrB	30.3	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	GTGCTGCCGTGTACCGGGTCAGGCCCGGAAGCGGTTGATGGCGTCGATGTGCTGCGCGCGCATCTCGTGGTCGCGCACGCCGAGTCCTTCCTCGGGCGCGAGGCAGAGCACGCCGACCTTGCCCTGGTGCAGGTTGCGGTGGACGTCGTAGGCGGCCTGGCCGGTGTCCTCCAGGGAGTACACCTTCGACAGGGTCGGGTGGATCCTGCCCTTGGCGATGAGGCGGTTGGCCTCCCAGGCCTCGCGGTAGTTGGCGAAGTGGGAGCCGATGATCCGCTTCAGCGACATCCACAGGTAGCGGTTGTCGTACTGGTGCATGTAGCCGGACGTGGACGCACAGGTGACGATGGTGCCGCCCTTGCGCGTGACGTAGACCGAGGCGCCGAAGGTCTCGCGGCCGGGGTGCTCGAAGACGATGTCGACGTCCTCGCCGCCGGTCAGCTCGCGGATGCGCCTGCCGAACCGCTTCCACTCGCGCGGGTCCTGCGTGTGCTCGTCCTTCCAGAACGTGAATCCCTCGGCATTGCGGTCGATGACCAGCTCGGCGCCCATCTTCCGGCAGATGTCGGCCTTCTCCGGGGAGCTGACGACACAGATCGGGGTGGCGCCGCCGGTCAGCGCGAACTGGGTGGCGTAACTGCCGAGTCCGCCGCTCGCGCCCCAGATCAGGACGTTGTCACCCTGCTTCATCTGCGCGCCGTTGCGAGAGACGAGCTGCCGGTAGGCGGTGGAGTTGACCAGGCCGGGGGCGGCGGCCTCCTCCCAGGTGAGGTGCCCGGGTTTGGGCATGAGCTGGTTGGACTTCACCAGCGCGATCTCGGCGAGGCCGCCGAAGTTGGTCTCGAAGCCCCAGATGCGCTGCTCGGGGTCGAGCATCGTGTCGTCGTGGCCGTCGGGGGACTCCAGCTCGACGCTGAGGCAGTGCGCGACCACCTCGTCACCGGGCTGCCAGGCGTTGACGCCGGGGCCGGTGCGCAGGACGACGCCCGCGAGGTCGGATCCGATGACGTGGTACGGCAGGTCGTGTCGCTTGGCCAGCGGCGACAGCCTGCCATAGCGCTCCAGGAAGGCGAAGGTCGGCACCGGCTCGAAGATCGAGGTCCACACCGAGTTGTAGTTGACCGAGGAGGCCATGACGGCCACCAGGGCCTCGCCCGGGCCGGGCTCCGGCACCGGGACGTCCATGACGTGAAGGGATTTCCGTGGATCCTTCACCCGCGAGTCCACGCCGTCGAACATTCCGATGTCCTCACGCCGGACGGCAACGCCCCGATAGCTGTCCGGAAGGGGCAGTGCCGCGTAGTCGCCGGACGTTGCCGTACCGGAGAGGACGGCATCGACTATTTCCTTCACGTGGGGTTTCCTCCCGAGGCAGGCACGACGGTGGACATTACACCCGTATATGACCGGGCCGACCCTAGAAAATTCCCCGCTCCCGGGGCAACCCCCTAA	MLPCTGSGPEAVDGVDVLRAHLVVAHAESFLGREAEHADLALVQVAVDVVGGLAGVLQGVHLRQGRVDPALGDEAVGLPGLAVVGEVGADDPLQRHPQVAVVVLVHVAGRGRTGDDGAALARDVDRGAEGLAAGVLEDDVDVLAAGQLADAPAEPLPLARVLRVLVLPERESLGIAVDDQLGAHLPADVGLLRGADDTDRGGAAGQRELGGVTAESAARAPDQDVVTLLHLRAVARDELPVGGGVDQAGGGGLLPGEVPGFGHELVGLHQRDLGEAAEVGLEAPDALLGVEHRVVVAVGGLQLDAEAVRDHLVTGLPGVDAGAGAQDDAREVGSDDVVRQVVSLGQRRQPAIALQEGEGRHRLEDRGPHRVVVDRGGHDGHQGLARAGLRHRDVHDVKGFPWILHPRVHAVEHSDVLTPDGNAPIAVRKGQCRVVAGRCRTGEDGIDYFLHVGFPPEAGTTVDITPVYDRADPRKFPAPGATP	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	245.18	gnl|BL_ORD_ID|1654|hsp_num:0	1794			357	456	tunicamycin
BGC0001355.1|U-68204_8 # 6882 # 8657 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=4bp;gc_cont=0.724	BGC0001355.1|U-68204_8 	6882	8657	+	Loose	200	35.8094	vanH gene in vanP cluster	42.86	3007188	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGCACCCCAAGACGGTGGAAGAAGCGGTCGTCGGAGTCGTGGGACTCGGGACCGTCGGAGAAGCCCTGCTGGGCCTGTTGAACGAGGCGGGCTGTCGGGTCGTCGGAGTGGACCGCGACCTCGACGTACTGGCCAGGGTCGAGCAGCGCCTCAAGGCGCGCGGGGAGGGCGGTGCCTTCGACCAGCCGCCCCTGGCCCTGACGAGCGACATCGGCTCCCTGGCCGGGGCCGACTTCGTGATCGAGGCCGTGGACGAGGACCTGGCGGTCAAGAGCGGTCTGCTGCACCGGCTGCACGGGGTCTGCGCCGATTCCGCCGTGTTCCTCACGACGACCGCCTCGCTGCCGCTGTTCCGCCTCGCCACCGCGTCCCGGCGCCCGGAGCGAACCGTCGGCCTGCGCCTGCTCAGGCCGCCTGCGGCGGGTGGCCGTGCCGACGTGGTGCCCACCTCGCTGACCTCGGGTGACGCGATCGGCGCGGCGAGGGAACTCACGACGGCTCTCGGCCTCGAACCCGCCGCCGTCGAGGCCCAGGCGGGCCGGTTCGCCACCGGGCTCGTCCACGCCTTCGTGAACCGTGCCGCCGTGATGGTCGCGCAGGGCTTCGTCGCCGCCCAGGACATCGACACCGCCATGCGCCTCGGCTGCGGGCTGCCGTCCGGCCCCCTGCAACTCATCGACGAACTGGGCGTGGACGAGGTGCACGCCGGCCTCACCGCGCTGTGCGAGCGCACCGGTGACAGCCGGTACCGTCCGGCCCCGCTGCTCAGCTCGATGCTCGACCGCGGCACGCTCGGCCGGAAGAGCGGCCAGGGCTTCTACCGCTACGACGACACCGGTCGCCGGATCGCCGGATCGGACACCCCGCACACCCACGGCAGTTCGGCGGCGGCGCCTCTCGAGCACGTGGGGGTGCTCGGCTCCGGCACGATGGCGCGGGGCATCGCGGAGGCCTGCGCGGTGGCGGGGTTCCGGACCACGCTGGTCGCCCGGAGCCCGGAAAAGGCCGACGCGGCCCTGGCCTTCATCGAGAAGTCACTGGCCAAGGCCGTACGGCGGGGCAAGGTCACGCCGGCGGGCAGGGCACACGCCCTCACCTGCCTGACGACCGCCGACGACATGGTCGCTCTCGCCGACTGTGACCTGGTGATCGAGGCCGTCGCGGAGGACCTCCCGCTGAAGCGCAGCCTCTTCGCCCGGCTGGGCAGGGTGTGCCGGGCCGGCGCGCTGCTCGCCACGACGACGTCCAGCCTGCCGGTCGCCGCGTGCACGGAACCGGCGGGACGTCCCGAGGACACCCTCGGCCTGCACTTCTTCAATCCCGCGCCGGTGATGAAGCTGGTGGAACTGGTCCGCACCCCGGCCACGGGAGAGCGTGCCGTGGACGTCGCGCACGTGTTCTGCGGCGCGCTCGGCAAGGTCGCCGTCGGATGCCCCGACCGGGCCGGGTTCATCGTCAACCACCTGCTCTTCCCGTACCTCGCCGACGCGGTGCGGCTGCTGGACGAGCACGCGGTGGACGCCGCGGACATCGACGCAGCGATGGAACGCGGCTTCGGTTACCCCATGGGGCCCTACACGCTGCTCGACAGCATCGGACTGGACGTCTCCCTCGCCATCCTGCGCTGCCTGGACACGGAGTTCCCCAAGTCCGGGTACGAACCCCCCGTCCTCGTCGAGGAGTTGGTCGACCAGGGCATCCTGGGGCGCAAGTCGGGACGGGGGATACGCGGAGCCCGGGAACGGGTCAGCCCCGGCGCGACTCGAAACGGCTGA	MHPKTVEEAVVGVVGLGTVGEALLGLLNEAGCRVVGVDRDLDVLARVEQRLKARGEGGAFDQPPLALTSDIGSLAGADFVIEAVDEDLAVKSGLLHRLHGVCADSAVFLTTTASLPLFRLATASRRPERTVGLRLLRPPAAGGRADVVPTSLTSGDAIGAARELTTALGLEPAAVEAQAGRFATGLVHAFVNRAAVMVAQGFVAAQDIDTAMRLGCGLPSGPLQLIDELGVDEVHAGLTALCERTGDSRYRPAPLLSSMLDRGTLGRKSGQGFYRYDDTGRRIAGSDTPHTHGSSAAAPLEHVGVLGSGTMARGIAEACAVAGFRTTLVARSPEKADAALAFIEKSLAKAVRRGKVTPAGRAHALTCLTTADDMVALADCDLVIEAVAEDLPLKRSLFARLGRVCRAGALLATTTSSLPVAACTEPAGRPEDTLGLHFFNPAPVMKLVELVRTPATGERAVDVAHVFCGALGKVAVGCPDRAGFIVNHLLFPYLADAVRLLDEHAVDAADIDAAMERGFGYPMGPYTLLDSIGLDVSLAILRCLDTEFPKSGYEPPVLVEELVDQGILGRKSGRGIRGARERVSPGATRNG	MREIAVLGSSEEEKKIFKKYASAYQVTLRFYENIEQVCKEGRQSLLSISHAEDMSENNLKRLHQAGVEYISTRSIGLNHIDMAAAKRLDMQVNNVAYSPESVAEHTVMLMLMALRNMKNTEKNVEQYDYRLPKKRFRELRELTVGVVGTGRIGQTVIGLLRGFGCRIICYDTYQVEGLDYVSYEELLAESDIITYHIPLTEESLHMLNQDNIRLVKPGAYIVNTARGALIDNEALIAALESGQLAGAALDVVENEESFFYKKCKNVGQELALLSRMKNVVLTPHSAFYTSQALEDVVENSIKNCLEYKEEAVYA	188.22	gnl|BL_ORD_ID|4818|hsp_num:0	5804			408	513	vancomycin; teicoplanin
BGC0001355.1|U-68204_9 # 8629 # 11250 # -1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0001355.1|U-68204_9 	8629	11250	-	Loose	470	29.6462	sdiA	28.3	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGATCTATCAGCGCACGACATGCGGATGGCTGAAAACCCGGCCGTCCAGGAGGGAGCTGAGGTCCGCCGTGGAGACGGCAGAGCGGTGCAGGGCACAACGCCTTCTTGACGGCCTGGTGCAACAAGCGAGTGCGGGTAGGGGGCAGGCCGCACTCGTCCTCGGTCCCCCTGGGGTGGGCAAGAGCTCACTGGCCTCACACGTCCGGGCGCGCGCGGAGAGATCAGGCGCGGTCGTCGTGAGCGCCGTGGCGTCCGCGACGGAGCGTTCGTTCGCCTTCGGGATCGTCAGCCAGCTCCTTGCCGGGCTGGGCCGTTCCCCGGCCGCGCTCGCGACTCTCCACGAGGCGCCGGCCACGGCCGCCGGCGCCGTGTACGACGCTGTGTCCGCGGCGGCCGAGCAGACCCCCCTGATCGTGATCGTCGACGACGCCCACCACGTCGACGGCGAGAGTCTGCGGTGCCTGCTCCACGTCATCCAGCGTGTGGAGTCCCTGCGGGTGCTGCTCCTGCTCACCGCCCGCTCCGACCTGCCCGAGGACAACCTCGCGCTGACCGCCGAGTACGTGCGTAATCCCCGGTGCTCCCTGATCACCCTGGCAGCCCTGTGCTTGCAGTGCACTGAGAAGATCATCGCCGAACGTCTGGGCCCCGGCCCGGCTCACCGCGCGGCACCTGTCTGGCAACAGGCCTCCGGCGGCAGTCCCTTGCTGCTCCAGGCGCTCGCGGCGGACTGGTCCACCCGTCAGGCGGCCGCCGGGCCGACGGCCCCGGCGGCCGGGACGCCGGCCGAGCCGCCGGAGGACGGAAGCGCCGTACGGTTCGCCGTCCAGTACATCCACGACCTGCTGACCGACGACGTCCTGCGCACCGCGCGGGCTCTCGCCGTCCTGGGCGACGCGGCGACCACGGAACGGGTGGAGCGGCTGCTCCACATGCTCGACATGTCCGCCAGCGAGGCCGTGCGCGCCCGTGGCGTCCTGGAAGCCGCGGGTCTGACCGACGGGACGCGCTACCGCCTGGCGGCCTCTCGCCTCGTGGTCCTGGACAGGACACCGGCCGAGGAGCGGGAACTGCTGCACCGCACCGCCGCCCAGGCCCTGCGGGAGAGCAACGCGGATCTGACCGAGGTGGCCGGTCACCTGGTACAGACGCGTCCCCTGCACGAGGACTGGGCGGTCATCGCGCTACGGGGAGCCGGCGCGCAGGCCCTGCACGACCAGGACGCCGAGCGGGCCATCACGTTCCTCCGAGCCGCCTACGCGGCGTGTGCCGACGGTCCGCTGCGTGCGACGGTCATGGCCGAACTGGCCCAGGCGGAATGGGAGGTGGACCCGGGCGCGGTGCGCTGGTACCTGACCGATCTGCTGGACGGCCACCGCGCCGGGCGCCTGAGCCGGAAGCACAGTGTTCTGCTCGTGGTGTATCTGCTGTGGTCGGGACGGCCCCAGGAGGCGGACGAGATCCTCGCCGGCCTCGATGCCGCGCCAGGGGAGTGCACCGACGAGTTGCAGGCCCGCCTGAACGCACTGCATGTGTGGTTCGCGTACTTCTACCCGACCTTCGGCACCCGGTACCACCACGGCCCCCCGGTGTCCGGGCCCGACCCCGGTCAGAGCGTCGTGTCCGTCGACCCGCACCGCGACGGAGCCCTCATCCTCACCTCGCTGCTCACCAACGGCCCGACCGAAGGGGCACGTGACGCGGCCGAACGGCTCCTGCAGGCCCTGATCCCGCACAACCCGCCGGTGGCTCCGGCGATGGCCGCGCTGATCGCCCTCATCCGTGCGGCACGTCTGGAGCGGGCTGCCGAGTGGTGCGAGGCACTGGTGGCGGACCACACGCGGCGCACCCCCACCGCGCAGGCGATCCTGCTCGCGTCCAGCGCGATCCTGGAGAGCTGGCTGGGCAACTTCACGACGGCGCGGGAGCGCGCGGAACAGGCACTCGGCCTGCTCCCCGCGGCCGCGTGGGGCGTCGCCATCGGTCTCCCCCTGTCCGCGAAGGTGCTGGCGTGTACCGCCCTCGGGGACGCCGAGGCGTCGGCCGAGTGTTTCCGGATCCCGGTGCCTCAGCTGATGTTCCAGACGCTGCCCGGTCTGCACTACCTCCAGGCCCGCGGCCGGCACCACCTGTCCGAGGGCCGCTACCGGGCGGCGCTCGGTGACTTCTATGCCTGCAGGGACCTGATGGTGGCCTGGAAGCTCAACGTCTCCGTGTTCACGGCCTGGCGCGTGTACGCGGCGGAGGCGCAGATCGCCCTGGGAGACCTGGCGGAAGCGGACCGGCTGCTGAACGAGGAACTGGGTCAGCCGGACGCCGGGAGTCCCTGGCTGCGCGAGCAGGCACGTCTCCTGCACGAGCGGCTCCGCAGCGCGCGGGCACGGGCCGGGTCGGACGAGGCGGCACCCGGCGCCGACGTACCGGTGAGGCTGAGCAAGGCGGAGCACCGGGTCGCCCGGCTGGTCTGCGAAGGGCTGACCAACCGGGAGATAGCCGCCCGGCTGTGTGTCACGCCCAGCACGGTCGAGCAGCATCTCACCCGGGTCTACCGGAAGCTGGGGGTCCGGGGCAGGGCCGCCGTTCCGGTGGCGCTCAGCCGTTTCGAGTCGCGCCGGGGCTGA	MIYQRTTCGWLKTRPSRRELRSAVETAERCRAQRLLDGLVQQASAGRGQAALVLGPPGVGKSSLASHVRARAERSGAVVVSAVASATERSFAFGIVSQLLAGLGRSPAALATLHEAPATAAGAVYDAVSAAAEQTPLIVIVDDAHHVDGESLRCLLHVIQRVESLRVLLLLTARSDLPEDNLALTAEYVRNPRCSLITLAALCLQCTEKIIAERLGPGPAHRAAPVWQQASGGSPLLLQALAADWSTRQAAAGPTAPAAGTPAEPPEDGSAVRFAVQYIHDLLTDDVLRTARALAVLGDAATTERVERLLHMLDMSASEAVRARGVLEAAGLTDGTRYRLAASRLVVLDRTPAEERELLHRTAAQALRESNADLTEVAGHLVQTRPLHEDWAVIALRGAGAQALHDQDAERAITFLRAAYAACADGPLRATVMAELAQAEWEVDPGAVRWYLTDLLDGHRAGRLSRKHSVLLVVYLLWSGRPQEADEILAGLDAAPGECTDELQARLNALHVWFAYFYPTFGTRYHHGPPVSGPDPGQSVVSVDPHRDGALILTSLLTNGPTEGARDAAERLLQALIPHNPPVAPAMAALIALIRAARLERAAEWCEALVADHTRRTPTAQAILLASSAILESWLGNFTTARERAEQALGLLPAAAWGVAIGLPLSAKVLACTALGDAEASAECFRIPVPQLMFQTLPGLHYLQARGRHHLSEGRYRAALGDFYACRDLMVAWKLNVSVFTAWRVYAAEAQIALGDLAEADRLLNEELGQPDAGSPWLREQARLLHERLRSARARAGSDEAAPGADVPVRLSKAEHRVARLVCEGLTNREIAARLCVTPSTVEQHLTRVYRKLGVRGRAAVPVALSRFESRRG	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	363.75	gnl|BL_ORD_ID|207|hsp_num:0	228			531	690	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001355.1|U-68204_10 # 11661 # 12866 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=9bp;gc_cont=0.739	BGC0001355.1|U-68204_10 	11661	12866	+	Loose	750	332.798	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	47.07	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGGACGTATGGGTTACGGGCCTGGGCGCCCTGACGCCGGTCGGCGCCGACATGGCGAGCACCTGGGCCGCGCTGCGGGCCGGTGCCAACGGGGTCGCGTACATCGACGAGAAGTGGGCCGAAGGGCTCCCCGTGCGTATCGCCGCGCGTCTCACGGCGGACCCCGCCGACTCCCTTGCCCGCACCGAGGCCCGCCGCCTGGACCGGGCCGAACAGACGGGGCTGGTCGCCGCGCGGGAAGCCTGGCGCGACGCCGGCTCGCCCGACGTCGACCCGGAGCGCCTCGCGGTGGCCGTGGGCACGGGCATCGGGGGTGTCACCTCGCTCCTCGCCCAGAACGACCTGCTGGCCTCCAAGGGGCCGCGCCGGGTCTCCCCGCACACCGTGCCCATGCTGATGGCGAACGGGCCCGCGGCCTGGATCAGCATGGACCTGGGCGCACAGGCCGGCGCCCACGCCCCGGTCAGTGCCTGCGCGTCCGGCGCGGAGGCGATCGCCCTCGGGCTGGACCTGATCCGCGCAGGCCGCGCCGACGTCGTGGTGGCGGGCGGCGTGGAGGCCAGCGTCCTGCCGCTGCCGCTGACCGGCTTCGCGCAGATGATGGCCCTGTCGACCGCGAACGACGATCCGGCCCACGCCAGCCGCCCCTTCGACGCCCGGCGCCACGGGTTCGTCCTCGCCGAGGGCGGGACGATCGTCGTGCTGGAACGGGCGGAGCATGCGCGTGCTCGCGGGGCGCGCGCGCACGCCGCGGTGCTCGGGGCGGGTGTCGGCTCGAGCGCCGCCCACATCACGGCGTCCGACGTGCCCGGGCAGGTCCGGGCCATGACCGCTTCCCTGCGCGATGCCGACGTCGGACCCGGTGACGTCGACCATGTGCACGCCCATGCCACCTCCACACCCCAGGGAGATCTGGCGGAGGCCAAGGCGCTCGCTCAGGCCATCGGAACGCATCCGGTGGTGACGGCGACGAAATCCATGACCGGGCACATGCTGGGCGCTTCCGGGGCGATGGGGGCGGCCGCCGCGATCCTGGCGCTGCGCGACGGCACGGTGCCGGCCATCCGCAATCTGGACGAGGTGGATCCAGAGGTGGAACTCGACGTCGTCAGGGATGCACCGCGCAGCGGCCGGCTGGAAATCGCGCTAGCCAATTCCTTCGGTTTCGGCGGACACAATGTCTCCCTGGTCTTCGGCCGCGTCTGA	MDVWVTGLGALTPVGADMASTWAALRAGANGVAYIDEKWAEGLPVRIAARLTADPADSLARTEARRLDRAEQTGLVAAREAWRDAGSPDVDPERLAVAVGTGIGGVTSLLAQNDLLASKGPRRVSPHTVPMLMANGPAAWISMDLGAQAGAHAPVSACASGAEAIALGLDLIRAGRADVVVAGGVEASVLPLPLTGFAQMMALSTANDDPAHASRPFDARRHGFVLAEGGTIVVLERAEHARARGARAHAAVLGAGVGSSAAHITASDVPGQVRAMTASLRDADVGPGDVDHVHAHATSTPQGDLAEAKALAQAIGTHPVVTATKSMTGHMLGASGAMGAAAAILALRDGTVPAIRNLDEVDPEVELDVVRDAPRSGRLEIALANSFGFGGHNVSLVFGRV	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	96.39	gnl|BL_ORD_ID|1968|hsp_num:0	1943			72	1248	isoniazid
BGC0001355.1|U-68204_11 # 12941 # 14215 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=4bp;gc_cont=0.667	BGC0001355.1|U-68204_11 	12941	14215	+	Loose	400	27.335	ErmE	31.51	3000326	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAGCCCATAAAAGCGAGGGTGAGTGTCCCCTCTCACTCGGCCGTGACTTCTTCGAGGACCCGCACTCGGTCTACCGAGTCATCAAGGAAAACGGAAACAGACCGACGAAGGTCGTGTTCGAGACGGGAATGGCCTACCTCCCGCCGAATCTGCGCGCCTGGGTCGTGACCGCGTACGAGGACATCGAAGTCGTTCTGCGAGATCCGCGGTTCTGCAAGAGCATCGACGAGGCCATGGCGTTGTTCCGGGCGAACAGCCCCGACGGTGAGCAGACGCGGGAACGCAGTTCGCTGCTGTACGACAACATGGCCAACAACGACCCTCCGGCCCACACCGCCCTGCGCAAGCCGCTCAACAGCGCCTTCACCGCGCGCGCCGTGGCGACCAAGCGCGAGGCCATGGAAGAGCTGGCCGATTCGGTGCTGGACGCCGTGGCCGGGCAGGAGACCTTCGACCTCGTCCAGGACTTCGCGTTCCCCTACTCGATATCCGTGATATGCGGCATGCTCGGGGTTCCGCGCGAGGACCGCGGCGCTTTCCACGCGTGGGTGCAGACGATCACCGGGGACGCCGCCTCCACGGCATTGGCCCGCGCCACCGAGCAGATGGTCGGTTACCTGCGCAAACTGATTCGTGACAAGCGCGGGGGCGACGCCGGTGACATCCTGACGCAACTCGCCGTGTCGTTGGACGAGTCGCAGGCCGTCGCGCAGGCATATGCGCTGCTCGCCGCGGGTTACGAGACGACGGCGAACCTGATCGTCACCGGTTTTCTCACCCTGGAGTCCACCCCGGAGCAAAAGGCCCGGCTGTGGCGCGACCGTTCACTCGTGCCGACGGCGGTCGAGGAGATGCTGCGCCACCAGTCCCCGTTCAACCTGTCGCTGTACCGGTACACCACCGAGGCCGCCGAGGTGGGCGGCGTGATGATCCCGGCCGGTTCCCTTGTCTTCCTCGCCTTCGCCGCGGCCAACCGGGACCCCGAGCGGTTCACGGATCCCGACACCTTCGACTTCGGCCAGCCGCGCCGTGAACACCTGGCTTTCGGCGGGGGCGTCCACAACTGCATCGGCAAGCATCTGGCCCGGCTGGAGACGGAGGTCGCCTTTCACGCGCTGATCGAGCGCTGTCCGGACCTCCGTGTCGTCATGCCGAGGGAACGGATGGAGTGGAAGGCGAGCCCGACCTTCCGGGGACTGCGGAACCTGACCGTCGGACCGGGGCCGTCGCCCGCCCCGTCCTGCGCCCCCGAAAAGAGGGCCGTCTCGTGA	MTAHKSEGECPLSLGRDFFEDPHSVYRVIKENGNRPTKVVFETGMAYLPPNLRAWVVTAYEDIEVVLRDPRFCKSIDEAMALFRANSPDGEQTRERSSLLYDNMANNDPPAHTALRKPLNSAFTARAVATKREAMEELADSVLDAVAGQETFDLVQDFAFPYSISVICGMLGVPREDRGAFHAWVQTITGDAASTALARATEQMVGYLRKLIRDKRGGDAGDILTQLAVSLDESQAVAQAYALLAAGYETTANLIVTGFLTLESTPEQKARLWRDRSLVPTAVEEMLRHQSPFNLSLYRYTTEAAEVGGVMIPAGSLVFLAFAAANRDPERFTDPDTFDFGQPRREHLAFGGGVHNCIGKHLARLETEVAFHALIERCPDLRVVMPRERMEWKASPTFRGLRNLTVGPGPSPAPSCAPEKRAVS	MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELRPDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAEPPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTWPLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGRPGRRGGPGQR	111.29	gnl|BL_ORD_ID|94|hsp_num:0	109			111	312	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001355.1|U-68204_14 # 23106 # 25790 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=10bp;gc_cont=0.719	BGC0001355.1|U-68204_14 	23106	25790	+	Loose	1000	135.961	almE	28.35	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACTCGCTCGCTGACACCGCCTGGCTGGAACCCGTCTGGGCACGCGACCCCGTCCTGGGCCCCGGGGCGTGGCCGGGCGAGGCGGACCGGCCCACCGAGCCCGGCGCGGACGCGCTGCTCCACCACCGGTTCGTCGCCCAGGCGGCTCGCACCCCCGACGCGGTGGCCGTCATCACCCCCGACCGCCGGCTCAGCTATGCCGAGGCCGCTCGGGAGTCGGCGGGTGTCGCCCACCGTCTGACGGAGGCCGGCACCGCCCCGGGGGACCTCGTCGGTGTGGTGATGGAGAAGGGATGGGAGCAGGTCGTCGGGTGCCTGGGCGTGGTGCGGGCCGGTGCCGCGTACGTGCCCCTCGACCCGCACTGGCCGGCCCGGCGCCTGCGTGACGTCCTCGCGGCGGCCGGCACGAGCACCGTGCTCACCCAGCCGTCCGTGCGGGACGCCGTGGACTGGCCCGACGGGATCGAGGTGCTGGAGGTCACGGTGCCGGACTCCGGCACGGCCCCGGCCGAGGCGCCGGACGTTCCGGTGAAACCCGGCGACGTCGCGTACGTCATCTACACATCCGGTTCCACCGGTGTGCCCAAGGGAGTGGTGATCGAGCACGGTGCGGCCGTCAACACGGTCCAGGACGTCAACGAGCAGATCTCGCTGACGGCCGACGACCGGGTCCTGGGCCTGTCGGCGCTCACCTTCGACCTGTCCGTGTACGACATCTTCGGCCCGCTCTCCGTCGGTGGCGCCGTCGTGCTTCCCGCACCGGAGGACGCACGCGAACCGGCCCGCTGGCTGGAACTGATGAACGAGTCGGGCGTCACGGTCTGGAACAGCGTGCCCGCGCTGATGGCCATGCTGTGCGAGTACCTGACCTCGGCGACGGACCAGGCGTCCACGGCCCCCGACGGCCCGCCGCCGCTGCGGACCGTCCTCATGAGCGGTGACTGGATACCGGTCACGTTGCCGGCGGAGATATGGCGCTTCTTCCCGCAGGCCGTGCTGTGGAGCCTCGGCGGTGCGACGGAGGCGTCGATCTGGTCGATCCGGCACCGCATCACCCCGGCCGACGCTTCCCTGCCGTCCATCCCCTACGGCACGTCCATGCGGAACCAGCGGGTCTTCGTCGCGGACCGGCTCCTGCGGCCGCGCCCACCGTGGGTAACCGGGGAGATCTGCATCGCCGGCGCCGGCCTCGCCCGCGGCTACCTCGGGGACGAGGAACGCACCGACCGGAGCTTCGTCACCTCACCGCTGACCGGTGAGAGGACCTACCGCACGGGCGACTGGGGGCGGCTGCTGCCCAGCGGTGAGATCGAGTTCCTCGGCCGCGAGGACATGCAGGTGAAGGTAGGTGGCTACCGCATCGAGCTGGGTGATGTGGAAGCCGCGCTGATGCGCTGCGACGGTGTCGCCGCGGCGGTCGCGACCGCGCCCGGTGACCGGGGCAGGGTGAAGCTGGTCGCGCACGTCGTCCTGGACGCCGACTCCGAGCTGACCGGCGGGGACATCAGGGAGGCGGTCGGCGCGTTCCTCCCCCCGTACATGGTTCCGGCCCACGTCATGGTGCGGGACGAGCTGCCGCTGACCAGGAACGGAAAGGTGGACCGGGCGGCGCTCGCCCAGCTGCCCGGGGAGGCCGCCCCGGCCGACGAGGACGCTCTCCCCACCACCGCGGAAGAACACTTCCTCCTCTCCGTCTGGCGGAGCTTCTTCGAAGCGCCTGCCCTGTCCGTCCTGGACAATTTCTTCGAACTCGGCGGCGACTCGCTGCAAGCGGTGCGGATGATGTCCGTCCTGAGGCGGGAGGCAGGCGTCACGCTGCCCGTTTCGACGCTCTTCTCCGCCCCGACGGTACGCGAGCTGGCGCTCCGCGTCCGGGCGTCCCGGTCTGACGGTGACCTGCCCGAGGCGCCGGTGATCCCGCTGCGCACCACGGGAAGCGCCGTCCCCCTGGTGTTCCTCCACCCGGTGGGAGGTGGCGTCCTGTGCTATTCCGACCTGGCGCGCAGCCTGGGGGACGACCAGCCGTTCTACGCCGTGCAGTCGCCGGAGGACTCCGGAACCGAAGACGCCACGCTGACCGAATTCGCCGCCGCGTATGCGAAGGCCATCACGCAGACCGTGCCGGGGGAACGGTTCCGGCTCGGCGGCTGGTCCATGGGCGGCCTGCTCGCCCTCGAGACGGCCAGGGAGCTTCGGGCGCTCGGATACACCGTCGACTCAGTAGCCGCCATCGACGTGCTGGAGGGCCCGGAGGAGCTGCGGCGCGCCCCGCTGACCGACGGCGAACTGCTGATGTGGCTGGGCAGGGATCTCGCAGGAACGGCAGGTGTGCCCTGGCGGCCGTCGGCTCCGGTCACCACACCCGACGAGCTGTACGGCGCGCTGGGCGCGGCCGGAGTGCTCTCCGCGGAGCTGGGCCGGCCCGAGTTCCAGAAGGTGTACCGCCGCTTCGCGCGCAACGCCCGGGCCCTGTACGGGTACCGGCCGGCCGGGTTCGACGGCCCGGTCCTCTTCCTGCAGGCGGAGTCCGGAGCGGCCCCCGACGTGGTCGAGGGCTGGCGGCAGCTGTGCCAGGGCCGCTTCGAGCAGATGACGATGGCCGGCGACCACTACACGATCGTGCAGAAGCCGAACGTAGCCGCCGTGGCCAAGGCCCTGAGCGACTTCCAGGAGAACCACTGA	MNSLADTAWLEPVWARDPVLGPGAWPGEADRPTEPGADALLHHRFVAQAARTPDAVAVITPDRRLSYAEAARESAGVAHRLTEAGTAPGDLVGVVMEKGWEQVVGCLGVVRAGAAYVPLDPHWPARRLRDVLAAAGTSTVLTQPSVRDAVDWPDGIEVLEVTVPDSGTAPAEAPDVPVKPGDVAYVIYTSGSTGVPKGVVIEHGAAVNTVQDVNEQISLTADDRVLGLSALTFDLSVYDIFGPLSVGGAVVLPAPEDAREPARWLELMNESGVTVWNSVPALMAMLCEYLTSATDQASTAPDGPPPLRTVLMSGDWIPVTLPAEIWRFFPQAVLWSLGGATEASIWSIRHRITPADASLPSIPYGTSMRNQRVFVADRLLRPRPPWVTGEICIAGAGLARGYLGDEERTDRSFVTSPLTGERTYRTGDWGRLLPSGEIEFLGREDMQVKVGGYRIELGDVEAALMRCDGVAAAVATAPGDRGRVKLVAHVVLDADSELTGGDIREAVGAFLPPYMVPAHVMVRDELPLTRNGKVDRAALAQLPGEAAPADEDALPTTAEEHFLLSVWRSFFEAPALSVLDNFFELGGDSLQAVRMMSVLRREAGVTLPVSTLFSAPTVRELALRVRASRSDGDLPEAPVIPLRTTGSAVPLVFLHPVGGGVLCYSDLARSLGDDQPFYAVQSPEDSGTEDATLTEFAAAYAKAITQTVPGERFRLGGWSMGGLLALETARELRALGYTVDSVAAIDVLEGPEELRRAPLTDGELLMWLGRDLAGTAGVPWRPSAPVTTPDELYGALGAAGVLSAELGRPEFQKVYRRFARNARALYGYRPAGFDGPVLFLQAESGAAPDVVEGWRQLCQGRFEQMTMAGDHYTIVQKPNVAAVAKALSDFQENH	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	160.79	gnl|BL_ORD_ID|4935|hsp_num:0	5928			300	1635	colistin A; colistin B
BGC0001355.1|U-68204_15 # 25855 # 27099 # -1 # ID=1_15;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0001355.1|U-68204_15 	25855	27099	-	Loose	750	311.612	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	45.6	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGGAATCTCCACAATTCAAGGAGGCTCGGGTGACCCGTAACGGTGGTGTGCTGGTGACGGGCGTCGGCGCGATGACGCCGCTGGGAGTCGATGCGCCGTCGTCGTGGTCGGGGCTGCTGGACGGCAAGTCGGGAGTGCGTTTCCTGGAGGAGGAGTGGGCCGCGGACCTGCCCGTGCACGTCGCGGCCGGGCTCACGGTGGACCCGGCCTCCCTGCTTCCGAGGACCGAGGCCAGGAAGCTGGACCGCGGGGAGCAGGTCGCCGTCCTCACTGCGCGCGAAGCCTGGGAGGACGCCGGTGCCCCGCAGGTCGAGCCGGAACGACTTGCCGTCGTCATCGGTACGGGGACCGGTGGTGTCCTCACCACACTGGGGCAGGACGACGTCTTCGAACGCGCCGGGGCTCGCCGGCTGTCACCGTTCGCGGTCCCCATGCTGATGCCCAACGGGCCGGCTGCCTGGGTGAGCATGGACCTGGGCGCGAAGGGAGGCGCCAGGACTCCGGTCAGTGCCTGTGCGTCCGGGGCCGAGGCCCTCGCCCTGGGGCAGGACCTGATCCGCAGCGGGCGGGCGGACGTGGTCGTCGCCGGTGGGGTGGAGGCCTGCCTGCACCCCTTCACCATCGCGGCGTTCGCCCAGATGAAGGCCCTGTCGACGCAGTCCGTGGACCCGGAAGCCGTGTCCCGCCCGTTCGACGTCAGGCGGTCCGGGTTCGTCATGGGCGAGGGCGCGGGGATGATGGTTCTCGAACGCGCCGAGTTCGCCCGGGCCCGTGGCGCACGTGCCCACGGCACGCTGGCCGGCAGTGCCGTGAGTTCGAGCGCGCACCACATCACGGCCTCCGACGCGGACGGCCAGGCCTTCGCCATGGAACTGGCGCTGCGCGACGCCGGCCTGGCCCCGGCGGACATCGGGGTCGTACACGCCCACGCCACCTCGACGGAGTCCGGTGATCTGGCGGAGGCCGAGGCGATCGGCCGGGCGATCGGCAGCCACGCCGCGGTGACGGCGACGAAGTCGATGACCGGCCACATGATGGGCGCGTCCGGAACGGTGGGCGCCATGGCCGCTCTGTTCGCGCTCCGGGACGGCACGGTGCCGGCCACGCGCAACCTCGACGAACTCGACCCGCGCGTGGAACTGGACGTGGTGCGCGGGGAGCGGCGCACCGGTCGGTGGTCCGCTGCGCTGGCCAACTCGTTCGGGTTCGGCGGACACAACGTCAGCCTCGTCCTCACCACGTGA	VESPQFKEARVTRNGGVLVTGVGAMTPLGVDAPSSWSGLLDGKSGVRFLEEEWAADLPVHVAAGLTVDPASLLPRTEARKLDRGEQVAVLTAREAWEDAGAPQVEPERLAVVIGTGTGGVLTTLGQDDVFERAGARRLSPFAVPMLMPNGPAAWVSMDLGAKGGARTPVSACASGAEALALGQDLIRSGRADVVVAGGVEACLHPFTIAAFAQMKALSTQSVDPEAVSRPFDVRRSGFVMGEGAGMMVLERAEFARARGARAHGTLAGSAVSSSAHHITASDADGQAFAMELALRDAGLAPADIGVVHAHATSTESGDLAEAEAIGRAIGSHAAVTATKSMTGHMMGASGTVGAMAALFALRDGTVPATRNLDELDPRVELDVVRGERRTGRWSAALANSFGFGGHNVSLVLTT	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	99.52	gnl|BL_ORD_ID|1968|hsp_num:0	1943			81	1239	isoniazid
BGC0001355.1|U-68204_12 # 14212 # 16332 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=CGAA;rbs_spacer=14bp;gc_cont=0.728	BGC0001355.1|U-68204_12 	14212	16332	+	Loose	750	57.3806	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	27.45	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGACCGTGACGACGCCTGCGATCGACACCACGGCGCCCATCGCCGTAGTGGGCATGTCCTGCAGCTTCCCGGGTGCCACCCACCCGGTGGGCTTCTGGGACAACCTCATGTCCGGCCTGGACAGCGTGGGTACGGTCCCGCAGGGCCGCTGGGAGCAGTGGCTCGGGGACGGGCCCGCCGTACCGGGCACACCCGTCACGCAGGGCGGCTTCATCGACGGACCGGACGCGTTCGACGCCGGGTTCTTCGGCATCGCGCGCCGGGAGGCCGAGCACATGGATCCGCAGCAGCGGCTCCTGCTGGAGCTCGCCTGGCAGGCCCTGGAGGACGCCGCCGTCGCCCCGTCGGCCGTGCACGGCGCTCCCTGGGGGGTGTATGTCGGGGCGTGCGCCGACGACTTCCGGACCCGGTACCTCGCCGCGGGCCGACTGGACAGGTTCGGGCACATGGGTACGAGCCGGTCCCTGCTGGCCGGCCGCCTCTCCCACCACTTCGGTCTGCACGGGCCCAGCGAGGTGATCGACACGGGCCAGTCGTCGTCGCTGTGCGCTCTGCACCGAGCCGTCACGAGCCTGCGGCTCGGCGAGTGCGAGGGAGCGCTCGTCGCCGGGGTCAACCTCAATCTCCTGCCCGAGGTCACCGAACAGGTCCGGCTGTGGGGCGGGCTGTCCGCGGACGGCCGCTGCCGCACGCTGGACGAGCGCGCCGACGGTTACGTACGGGCGGAGGGCGGTGGCTGCGTCGTCCTCAAGCCCCTGCACACCGCAGTACGCGACGGCGACCACGTCTACGCCGTCGTCCGGGGCAGCGCCACCAACAACGACGGTGGCCGGTCCGGGCTCGGTGTGCCCAGCCACGACGCCCAGTGCGAGGTCATCCGGGCAGCGCACCGCGCGGCCGGGGTGACGGCTGACCAGGTCGCCTATCTCGAACTGCACGGAACCGGTACGCCCGTGGGGGACCCGGTGGAGGCCCGGGCGGTGGCCACCGTCATCGGGCGGCAGCGGCCGCAGGCCGATCCGCTGCGGGTCGGCTCGGTGAAGACGAACATCGGGCACCTGGAGTCGGCCGCGGGGATCGCCGGGTTCATCAAGGCCTGTCTGGCCGTGCACCACGGTCAGCTGCCCCCCACCCTCCATCACCACCGCAGCCCCGCGGACCTGCCGCTGCGCGACCTCAACCTCCGCGTGGTCGTGCGGCCGGAGGAGCACACGTTCGGCACCGACGACGTCGTCGGAGTCAGCTCGTTCGGTATGGGCGGCACCAATGTCCACGTGGTCCTCGGGCCGCCTCCCGCACCCGTCTCCGCCGGGCCGGCCCACGGCCGGGACCGCGCCGAGCGCCCCGGCGCCGTGCTGTGTCTTTCCGGCCGTTCCCGGGAAGCGGTACGCGCGCTGGCCCGCGCTCTGCTGGACCACCCTCTCCCCACGCGGAGCCGCTCCGTGGCCGACGTGGCGTGGACGCTGGCGCAGCGGGCCCAGTGGGAACACCGGGCAGCCGTCGTCGGCGGTGACTGGGACGAGATCCGTGAAGGCCTGCACAAGGTCGTCGCCGGTCACGACCTGGCCATGCCGGCCGGCTGGACGCAGGGCGCGGACCCGGGCCGCATCGCCACGGTCGGGGCCGCCAGCTCCTACGTGTACACCGGTGGCATCGCCGAGGTGGCACGGCATCTCGGCCCAGGGCTGCGCAAGGTCCCCGGTCTGCCCACCTACCCCTTCGAGCGGCACACGTTCGCGCTTCCGCGGCCCGTCCGCACGACCACGACGACGGCCCCGGCCCCGGAGCCGGAGTCGGCGCCCGACGGGCAGGACGCCACCGGGCCCCTGCTCGACGAGTGGACCCGGGCGAGCACCCCGGACCGGCTGTGGCTCATCCGCTCGTTCCTGGAGCGGGAACTGCTCACGGTGCTGGGCGAAGCGGGGGATTCACCCCTGCGCATCGACCCCGACCACACCTTCAACGACCTCGGCATCGACTCCATGTCCCTCCTCGAGTTCCAGGAGCGCATCGTCTCCGCGACGTCGCTCGCGATCCCGGAGTCGGTGCTTTTCGACCACCCGACCATCAACGAACTGGCGGCGCATGTGAACACCGAGATGGAGGCCATCCGTGGCTGA	MTVTTPAIDTTAPIAVVGMSCSFPGATHPVGFWDNLMSGLDSVGTVPQGRWEQWLGDGPAVPGTPVTQGGFIDGPDAFDAGFFGIARREAEHMDPQQRLLLELAWQALEDAAVAPSAVHGAPWGVYVGACADDFRTRYLAAGRLDRFGHMGTSRSLLAGRLSHHFGLHGPSEVIDTGQSSSLCALHRAVTSLRLGECEGALVAGVNLNLLPEVTEQVRLWGGLSADGRCRTLDERADGYVRAEGGGCVVLKPLHTAVRDGDHVYAVVRGSATNNDGGRSGLGVPSHDAQCEVIRAAHRAAGVTADQVAYLELHGTGTPVGDPVEARAVATVIGRQRPQADPLRVGSVKTNIGHLESAAGIAGFIKACLAVHHGQLPPTLHHHRSPADLPLRDLNLRVVVRPEEHTFGTDDVVGVSSFGMGGTNVHVVLGPPPAPVSAGPAHGRDRAERPGAVLCLSGRSREAVRALARALLDHPLPTRSRSVADVAWTLAQRAQWEHRAAVVGGDWDEIREGLHKVVAGHDLAMPAGWTQGADPGRIATVGAASSYVYTGGIAEVARHLGPGLRKVPGLPTYPFERHTFALPRPVRTTTTTAPAPEPESAPDGQDATGPLLDEWTRASTPDRLWLIRSFLERELLTVLGEAGDSPLRIDPDHTFNDLGIDSMSLLEFQERIVSATSLAIPESVLFDHPTINELAAHVNTEMEAIRG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	169.71	gnl|BL_ORD_ID|1968|hsp_num:0	1943			678	1242	isoniazid
BGC0001355.1|U-68204_13 # 16325 # 23122 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.726	BGC0001355.1|U-68204_13 	16325	23122	+	Loose	750	89.7373	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.58	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGGCTGAGCACACAACGGAGCCGGCGGACATCGCCGTCATCGGCATGGCCTGTCGCTACCCGGGCGGCGTGGACACCCCGGAACGTCTGTGGGAGCTCGTCAACGAGGGACGCGACGCGATCACCGAATTCCCCGCGAACCGGGAGTGGCACACCGAAGACCTGTACGACCCGACGTTCGTGCGCCAGGGAGGGTTCCTCCACGACGCCGACCTCTTCGACGCCGAGTTCTTCAACATCAGGGCCGCCGAGGCGGTCTCCATGGACCCCCAGCAGCGGGTGCTGCTCCAGGTCGCCTGGGAGGCGATCGAGCGCTCCGGCATCGTCCCGTCGAGCCTGAAGGGCTCGCAGACGGGCGTGTTCGTCGGGCTCATGGCGAACGAGTACGGCATGCCGCTGTGGAAGTGGCAGGACGAGACGGCCGGGTTCATGGGCACCGGCACCTCGCCGAGCGTGGCCTCCGGCCGCATCGCCTACCTCCTCGGCCTGGAGGGGCCGGCACTGACCATCGACACGGCCTGCTCGTCGTCGGGTGTCGCGATCCACACCGCCGTACGCTCCCTGCGCAGCGGCGAGACGGACCTGGCACTCGCGGGCGGCTGTACCGTCCTCGCGGGCCCGGGCATGTTCGTCGACTACGCCAAGAAGGGCGCGCTCTCCCCGGACGGGCGCTGCCGTACGTTCTCGGACACCGCCAACGGCACCGTGTGGGCCGAAGGCGCGGGCGTCCTCGTACTGGAGCGGCTCTCCGAGGCGAGGCGCAAGGGACGGCGCATCCTCGGCGTCATCAAGGGCACCGCCGTCAACCAGGACGGGGCGAGCAACGGCCTGACCGCGCCGAGCGGCAAGGCCCAGGTCAAGGTCATCAAGCAGGCGCTGGCCGACGCCCGGCTCACGCCCGGGCAGATCCAGCTCGTGGAGGCACACGGCACCGCCACCAAGCTCGGTGACCCCATCGAGGCCAACGCCATCCAGGCCACCTACGGGCAGGACCGGGCCGCCGAACCCGTCTGGATCGGGTCCTTCAAGTCGAACATCGGTCACTCCATGGCCGCGGCCGGCGTCGGCGGTGTCATCAAGTGCCTGATGGCCATGCGCGCCGGCACGATGCCCAGGACCCTGCACGTGGAGGACCTCAACTCCCACGTGGACTGGTCCTCCTCCGTGGACGTCCTGCGGGACAGCAGGCCGTGGGAGACCACGCCCGACGGCGTACGCCGCTGTGCCGTCTCCTCCTTCGGCGTCAGCGGCACCAACTCCCACGTCCTCCTGGAGAGCTGGGAAGAGCAGGAAGCCGTCCCCGACCCCGGTCCCGAGGATGCCGGCCGAGCCCACACCCTCACGCTCTCCGCCAAGACGGCGACCGCCCTGCGCTCCTACGCGGCGGCCGTCGCCGGCCACCTCGCCGCGAACACCGCACCGTTGGCGGCGACCGCTCAGGCACTGGCGACGCAGCGCGAGCACTACGACCACCGCGCGGTGGCGATCGGCACGGAACGCGGGGAACTCCTCGACGCGCTCCGGGCCTTCGCCGCGGGAGAAGAGGCCCCGTCGGTCGTCCAGGGCGAGGCCCGGCGCATCCGCCGTCCCGTCTTCGTCTTCCCCGGCCAGGGATCCCAGTGGGACGAGATGGCGGTACGACTCCTGGAGGAGTCCGACGTCTTCCGCCTGCGGGCCGAGGAATGCGCCGGCGCCTTCAAGCCGTACCTCGACTACGACCTGATGGCCGTCCTGTCCGGCGACGACCGCGAGACGGACCGCGACCGCACCGACGTCGTGCAGCCGCTCATCTTCACCATGATGCTGGGCCTCGCCGCGCTGTGGCGGTCCGTCGGCGTCGAGCCCGCCGCGGTGGTCGGACACTCCCAGGGCGAGGTCGCCGCCGCCTGCCTCGCCGGTGCGCTCAGCCTGGACGACGCGGCCCGCGTGGTGGCCTGCCGCAGCCGCGTCCTGGAGGAGCGGGGCCGCGGCGGCATGGCAGCGGTGGCCCTCGGCCGCGAGGAGGCGCTGGCGCTCACCGGGGAGGCGGGCGCCGACCTGGTCGTCGCGGCGTCCAACGGCCCGGCGTTCACCATCGTGTCCGGCGACGACGAGCCCGGCATCCGCCGGCTGCTCGACCTGTGCGAGGACCGCGGCGTGTACGCCCGTCGCGTCCCGGCGAAGTGCGCCTCGCACTCCCCGGTCATGGCCGAGCTCGAACACCCGATCACCGAGGGCCTCGACGGGCTGCAACCGGCCGTGGGAGAGGTGGCGTTCTTCTCCACGGTCGAAGGCCGCCGCCTGGAGGGCACGGAGCTGACCGCCGCGTACTGGTACCGCAACGTGCGCGAGCAGGTCCGGTTCGCCGAGACCGTCGAGGTCATGCTGACGCACGGCTACGACGCCTTCGTCGAGATCAGCCCGCATCCCGTCCTGATCTCCTCGCTGCAGCAGGTGCTGGAGCAGGCCGGCAGCGAGGCCCCCGTCTGCGCGACACTGCGCCGGGACCAGGGCTCGTACCAGCGCTTCCTCACCGCGGCCGGCGAAGCCCATGTCCAAGGGCACACCGTCGACTGGACGGCCGCCCACACCGGTGCGTGGCCCGAACGGCCCGCCCAGGCGGAGCTGCCCACCTATCCCTTCGAGGGCCGCCGGTTCTGGCTCCCGGCGCAGATGGACCGGACGGCGACGACGGTCCCCGCCACCGCGCCGCGCCGGGCGAGCGCCCGCATCGCCGAGGGCACCCACCCGTTCCTGACGTCCGTGGTCGAGACGGTCGACGGCACGGTGGTGATGAGCGGCCGGCTCTCCCTGCGCAGTCATCCGTGGCTGCTGGACCACCGGGTCGAGCAGACCCCGCTGCTGCCGGGCACGGCCTTCGCGGAGCTGCTCGTCTCCGCCGGCCGCGAACTGGGCTGCGAGAGCCTGGACGAGCTGGTGCTGCGCGACCCGCTGCCGGTGCCGGTCGACGGCGGCTTCGTCGACCTCCAGCTCACCGTCAAACCCGCGGATGCACAGGGCGCGCGGGCGGCAGCGGTCTTCTCCCGCCCGTCGGGCGACGACACCTGGGCGCACCACGTGGACGCGGTGCTGTCCCGGCCGCACACCGTGGCCCCCGCCGCCTGTGATCCCACGGCACCCGCGGACGCCACCCGGATCGATGCCGCCGACCTGTACGCCCGGCTGCGGAGCATGGGCTACGGCTACGGCGACGCCTTCCAGGGAGTACAGAGCGGGGAACAGGACGGAAACCGGGTCAGGTCCCGGGTCGTCCTGCCCCGGAGTGCCCGCATCAACCACCGTGGCTTCGCCGTGCATCCCGCCCTGGTGGACGCCGCTCTGCACGCCGCGGTGGGCTGCGGCCTCTTCGGCGCGCCGCAGCCCGGGGATGTCGCCGTCCCCTTCGTCTTCAGCGGCGTACGGACGGGAGAGGACAGCGACGCGGACGAGTGCTGGGCGCTGGCCCGTCAGGTGGCGCCCGATGCCATCGCGCTCACCCTGGTGGACGACGCGGGGCGCACCCTCCTGGACATCGAGCGCATCGTGGTGCGGGGACTCGCCCTGCCCGCTCTGCCGGCGGGCGGCGAGGAGGCCGCCCTCTACACGACCGAGTGGGCGCAGCTTGACGGCGAGGCGCCCGTCGACCAGCGGCTGTGCGTGGTGGGCGCGGACGGACGGCTGGCCTCGGCCCTGAGGGACGCGGCACGCTCCGGCATCGCGGTGGCGACCCTGGACGAGGCGATGCTCGTCGTCAAGGGTCTGCCCGGAACGTGGCAGATCGTCCTTCCCGCCCCGCAGGGCGCCCCCGGACGGAGCGTCGCCGAGCGGGTCCACGACTCCGCGGCCTGGGCCCTGGAGACGATCCAGCAGTGGCTGCGCGCCGAGGACCTGGACGGCCGGGCCCAGCTCACACTCGTCACGCAGAACGCCATCACCGTCACCGGCGACACCGTCCACGACCTCGGTCAGGGCGCCCTGTGGGGGATGGTGCGGTCCGCGCAGACCGAGAACCCCGGCCGCGTCCGCGTCATCGACGTCGACGAGCCGGCCGCCGACACGCCCCAGACCCTGCTGCGGGCACTGACCCGGTCCGAGGCGCAGCTGGCCGTACGCGCGGACCGCGTGCTGCTGCCGTACCTGTGGCCGCTCGCCGCCTCCGCGGGCCGGACCCCGGACCTCGGTGACGGCACCGTCGTGATCACGGGCGGCACGGGCACGATCGGTCGTGCGGTGGCCCGTCACCTGGTGACACGGTGGGGAGTGCGCTCACTGGCCCTGCTCAGCCGCAGCGGGCGGCAGGCCCCCGGCATCGCGGAGTTCACCGCCGAGCTGCACGGCCTCGGGGCGTCCGTCGCCGTCCTCGGCGTCGATGTGGCCCAGGCGGACAGCGTGCGCGGCGCACTCGCCCGGCTGCGCGCCGAACGGCCCCTGGTGGGCGTCGTCCACGCGGCCGGCCTGCTCGATGACGCCATCGTCACGAACATGACGCCGGACCAGCTGCACACCGTCCTGGCGAGCAAGGTCGACTCGGCACTGAACGTCGACGAGGCGACGCGCGAGGACCAGCTGCGCTTCTTCACGGTCTTCTCCTCCCTCTACGGCGTCCTGGGCGGCCCCGGACAGGCCAACTACGCCGGCGCGAACGCCTTCCTGGACCAGTTCGCCCAGTGGCGACGGACCCAGGGCCGGCCTGCCAACTCGGTCGCCTGGGGACTCTGGGCCGAGGCGACCGGCATGACGGGGCACCTGGACGAGGGCGACCTGCTGCGCCTGCGGCGTAACGGCGTGGCCCCGTTCGAGGTGGACGAGGGACTCGCGCTGTTCGACGCGGCGCTGGCCGGCGACGCGCCCGCCGTGGTCGCGGCGCGCCTGGCCGTGAGCGACGCGACCGAACACGGCCGGTCGACCGGACCGTTCCTGTTCTCCCGCCTGGTGGCGGAGACGAGCGGAGCCGTCGCCGCGACCCCGGTGGTCAGCGCGCCGAGCGCGCCCAGCGTTCCCGAGGTGCGACCGCCCCTGCCCGGCAAGGCGCCGCAGCCGGCCGCGGAGGCCGGACAGGACGCGGCCACGCCGGAAACCGCCTCGGTGGTGGACCTGCTGAGGTCGCCCGGTGCCTCGCACGACCAGCGTGCCGCCGGGCTGCTCTCCCTCGTCAAGGAGAGCGTGGCCGAGTTGCTCGGCACCGAAGCACGGCGGGTGGACGCCCAGAAGTCCTTCTACGAGATGGGCTTCGACTCGCTCACGTCGATGGAGCTGCGGGTCCGTCTCGGCCGGAAGCTCGGCACGCGGCTGGGTGCCACCGTCGTCTTCGACCACCCGACGCCGGAGGCCCTCGTCTCCCACATCCTGGACCTGTTCGTCGAGGACGACGACACCGGGGAAGCCGGCGAGCCGGCCGCGTCGGCCGCAGCGGAGGCACCGCCGCAGACCTTCGCCGCTCCCCGTCCGCGCGCCACGGCGGAGTGCACACGCACCACACGAGAGGACTCCCGGCCCGCTCTGCCGGACTCGGAGCCCTTTCCGCTGACCCAGCTGCAGGAGGCGTATCTGGCGGGCCGTGCCGGGGACTTCGAACTCGGCAACGTCTCCACCTACCTGTACGTGGAGGTCGACCTGACCGGCTTCGACGTCACGGCTGCCGAGCAGGCCCTCGACAGGCTCGTGCAACGGCATCCGATGCTGCGGGCCGTCTTCGACCCCGAAGCGGGCACCCAGCGGGTCCTCGGAACCGTCCCCAGGGTGTCGATACCCGTCGAGGACCTCACCCGGCTGACCGACGAGGAACGCGGGCAGCGGCTCACCGAGATCCACGACGAGCTGAAGGCCCACGACTTCGATGTCACCAGTTGGCCCCTGTTCCTGGTCCGGGCGACGCGTCTGACCGCGGCCGTGACCCGCCTGCACTTCGGACTCGACGTCCTGATATCCGACGGCGGCAGCACCGCCCTGCTCTTCAAGGAGTGGGCCGAGCTCTACCGCGACCCGGACACGGAGCCGGCCGAGCCCGCCGCGCGGTACGAGGAGTACGTCCGGAAGATGCGCGCCCACGCCGCGTCCCCGGACGCCGAGCCGAGCAGGTCGTACTGGCGTGAGCGCCTCGCCACACTGCCGGCGGCACCGGAACTGCCGCTCGCGTGCCGGCTCTCCGACGTGCCGGTGCCGGTCTTCAGCAACCGTTACCTCCGCGTCGACGCACCGGAGTGGGAGCAGTTCAAGCGCAACGCCGCCGCCGCGGGGCTGACCCCGTCCTGCGCGGTGCTCGCGGCCTACTGCCACGTGCTGGCGGCCTGGTCGAAGACGCCCGACTTCACCGTCAACTGCCTGGTCTCCCACCGAGGTTCGGTGCCCGGGCTGGACACCACCGGGGTGGTGGGCAACTTCTCCGCCACCAGCCTGCTCGAAGTCCACGTCGACCAGGCGTCCCCGTTCCGGGACTCCGCACGCCGCATCCAGCGGCAGTTGCTGCTCGACATGGAGCACACCGCGTACACGGGCCTCGACGTCCTGCGGGACCTGGGCCGGCGGGACGCGGGAGCCGGCCGGGCCCGCATGCCGGTGGTCTTCAACAGCGCCATCGGGGTCGGCGCGGCCGACGGCACGACGACCGGCCCGGTGGGTTCGCTGTGCCGCATGGGCGAGACCGGCGTGCCGGTGTGGAGCGGCGTCCGCACACCCCAGGTGATCCTGGACCACACGGCGTTCGAGGAGAACGGTGGCCTGATCCTCAACTGGGACGTGCTGGAGGACGTGTTTCCCGAGGGAGTCGTCGACTCGATGTTCTCCGCGTATGAAAGGCTGATTCGTGAACTCGCTCGCTGA	MAEHTTEPADIAVIGMACRYPGGVDTPERLWELVNEGRDAITEFPANREWHTEDLYDPTFVRQGGFLHDADLFDAEFFNIRAAEAVSMDPQQRVLLQVAWEAIERSGIVPSSLKGSQTGVFVGLMANEYGMPLWKWQDETAGFMGTGTSPSVASGRIAYLLGLEGPALTIDTACSSSGVAIHTAVRSLRSGETDLALAGGCTVLAGPGMFVDYAKKGALSPDGRCRTFSDTANGTVWAEGAGVLVLERLSEARRKGRRILGVIKGTAVNQDGASNGLTAPSGKAQVKVIKQALADARLTPGQIQLVEAHGTATKLGDPIEANAIQATYGQDRAAEPVWIGSFKSNIGHSMAAAGVGGVIKCLMAMRAGTMPRTLHVEDLNSHVDWSSSVDVLRDSRPWETTPDGVRRCAVSSFGVSGTNSHVLLESWEEQEAVPDPGPEDAGRAHTLTLSAKTATALRSYAAAVAGHLAANTAPLAATAQALATQREHYDHRAVAIGTERGELLDALRAFAAGEEAPSVVQGEARRIRRPVFVFPGQGSQWDEMAVRLLEESDVFRLRAEECAGAFKPYLDYDLMAVLSGDDRETDRDRTDVVQPLIFTMMLGLAALWRSVGVEPAAVVGHSQGEVAAACLAGALSLDDAARVVACRSRVLEERGRGGMAAVALGREEALALTGEAGADLVVAASNGPAFTIVSGDDEPGIRRLLDLCEDRGVYARRVPAKCASHSPVMAELEHPITEGLDGLQPAVGEVAFFSTVEGRRLEGTELTAAYWYRNVREQVRFAETVEVMLTHGYDAFVEISPHPVLISSLQQVLEQAGSEAPVCATLRRDQGSYQRFLTAAGEAHVQGHTVDWTAAHTGAWPERPAQAELPTYPFEGRRFWLPAQMDRTATTVPATAPRRASARIAEGTHPFLTSVVETVDGTVVMSGRLSLRSHPWLLDHRVEQTPLLPGTAFAELLVSAGRELGCESLDELVLRDPLPVPVDGGFVDLQLTVKPADAQGARAAAVFSRPSGDDTWAHHVDAVLSRPHTVAPAACDPTAPADATRIDAADLYARLRSMGYGYGDAFQGVQSGEQDGNRVRSRVVLPRSARINHRGFAVHPALVDAALHAAVGCGLFGAPQPGDVAVPFVFSGVRTGEDSDADECWALARQVAPDAIALTLVDDAGRTLLDIERIVVRGLALPALPAGGEEAALYTTEWAQLDGEAPVDQRLCVVGADGRLASALRDAARSGIAVATLDEAMLVVKGLPGTWQIVLPAPQGAPGRSVAERVHDSAAWALETIQQWLRAEDLDGRAQLTLVTQNAITVTGDTVHDLGQGALWGMVRSAQTENPGRVRVIDVDEPAADTPQTLLRALTRSEAQLAVRADRVLLPYLWPLAASAGRTPDLGDGTVVITGGTGTIGRAVARHLVTRWGVRSLALLSRSGRQAPGIAEFTAELHGLGASVAVLGVDVAQADSVRGALARLRAERPLVGVVHAAGLLDDAIVTNMTPDQLHTVLASKVDSALNVDEATREDQLRFFTVFSSLYGVLGGPGQANYAGANAFLDQFAQWRRTQGRPANSVAWGLWAEATGMTGHLDEGDLLRLRRNGVAPFEVDEGLALFDAALAGDAPAVVAARLAVSDATEHGRSTGPFLFSRLVAETSGAVAATPVVSAPSAPSVPEVRPPLPGKAPQPAAEAGQDAATPETASVVDLLRSPGASHDQRAAGLLSLVKESVAELLGTEARRVDAQKSFYEMGFDSLTSMELRVRLGRKLGTRLGATVVFDHPTPEALVSHILDLFVEDDDTGEAGEPAASAAAEAPPQTFAAPRPRATAECTRTTREDSRPALPDSEPFPLTQLQEAYLAGRAGDFELGNVSTYLYVEVDLTGFDVTAAEQALDRLVQRHPMLRAVFDPEAGTQRVLGTVPRVSIPVEDLTRLTDEERGQRLTEIHDELKAHDFDVTSWPLFLVRATRLTAAVTRLHFGLDVLISDGGSTALLFKEWAELYRDPDTEPAEPAARYEEYVRKMRAHAASPDAEPSRSYWRERLATLPAAPELPLACRLSDVPVPVFSNRYLRVDAPEWEQFKRNAAAAGLTPSCAVLAAYCHVLAAWSKTPDFTVNCLVSHRGSVPGLDTTGVVGNFSATSLLEVHVDQASPFRDSARRIQRQLLLDMEHTAYTGLDVLRDLGRRDAGAGRARMPVVFNSAIGVGAADGTTTGPVGSLCRMGETGVPVWSGVRTPQVILDHTAFEENGGLILNWDVLEDVFPEGVVDSMFSAYERLIRELAR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	544.47	gnl|BL_ORD_ID|1968|hsp_num:0	1943			438	1224	isoniazid
